University of Toronto: here's why a high-carb diet increases the risk of colon cancer

Editorial note: This article was previously published and has been updated according to scientific and informative criteria. For informational purposes only: it does not replace personal medical advice or diagnosis.

In brief

• Experimental studies indicate that certain metabolites produced by the gut microbiota, particularly butyrate, can influence the proliferation of intestinal cells in genetically predisposed animal models.
• The relationship between carbohydrate consumption, microbiota, and colorectal cancer risk is complex: it depends on the quality of carbohydrates, microbial composition, and the host's genetic and metabolic context.
• Observational evidence in humans is conflicting: some studies associate high glycemic index/glycemic load with increased risk, while other analyses find no clear association.
• Recent research lines show both potentially protective mechanisms (butyrate as an immune modulator and HDAC inhibitor in cancer cells) and, in some preclinical models, promoting effects in specific genetic contexts.
• For the public: prioritize the quality of carbohydrates (fiber and whole grains) and discuss any dietary choices with your doctor if you have high-risk genetic conditions.

Abstract: what does science say?

Simple definition: the central theme is the interaction between three elements—diet (especially carbohydrates), gut microbiota, and intestinal mucosal genetics—and how this interaction can influence the likelihood of colon cells developing alterations that precede or promote colorectal cancer.

What available evidence shows: experiments in murine models indicate that intestinal bacteria transform dietary carbohydrates into short-chain metabolites (including butyrate) that modulate the energy, epigenetics, and proliferative behavior of colon cells. In some genetically predisposed models (APC mutations and DNA repair system deficiencies like MSH2), increased butyrate levels are associated with hyperproliferation and a higher frequency of polyps; conversely, in other contexts, butyrate plays anti-inflammatory and anti-tumor roles through the activation of regulatory immune cells or as an inhibitor of histone deacetylases (HDACs).[1][2][3][4]

What depends on dose, frequency, context, or form of consumption: the effects vary based on the quantity and type of fermentable fiber/carbohydrate, the microbiota's ability to produce butyrate, the local concentration of the metabolite in the colonic lumen, and the metabolic/genetic state of the colonic cells (e.g., presence of the "Warburg effect" in tumor cells). Some experiments show that reducing the availability of fermentable carbohydrates or altering the microbial flora reduces polyp formation in predisposed models; reintroducing butyrate can restore proliferation in those same models.[1][2][4]

Interpretive limitations: the main evidence of mechanistic linkage comes from controlled animal models and cellular studies; human observational evidence remains equivocal and subject to dietary measurement bias, confounders, and interindividual variability. Therefore, a simple causal reading should be avoided: the presence of associations does not automatically imply that general dietary modifications will produce the same effects in all people.

Epidemiological framework: the relationship between carbohydrates and colorectal risk is plausible and supported by biological mechanisms described in the literature, but the strength and direction of the association in human populations vary depending on the quality of carbohydrates consumed, the microbial profile, and the genetic/clinical background of the studied population.[5][6]

Experimentation and counter-evidence

Key experimental results

The experimental work that stimulated extensive debate used mice carrying mutations that predispose to colorectal cancer (APC mutations and MSH2 loss-of-function). In these models, altering microbial composition with antibiotics or reducing fermentable carbohydrates in the diet reduced butyrate production, epithelial proliferation, and the number of intestinal polyps; conversely, the reintroduction of butyrate restored proliferation and tumors in those animals.[1]

The "paradox" of butyrate and the role of cellular metabolism

Mechanistic studies have shown that butyrate can act in opposite ways depending on the metabolic state of the colonic cell. In normal cells, butyrate is an energy source; in tumor cells that use aerobic glycolysis (Warburg effect), butyrate accumulates and can act as an HDAC inhibitor, promoting apoptosis and reducing proliferation. This explains why the same metabolite can sometimes be protective and sometimes a promoter, depending on the cellular and genetic context.[2]

What it means in practice

For the reader, the first rule is to differentiate quality and quantity: not all carbohydrates are equivalent. Experimental evidence does not, by itself, authorize generalized recommendations for low carb diets for the general population. However, the totality of evidence suggests that prioritizing fiber-rich carbohydrate sources (fruits, vegetables, legumes, whole grains) over refined carbohydrates (white flour, white rice, highly processed sweets) is consistent with a colorectal risk prevention strategy based on observational data and plausible biological mechanisms.[5][6]

If you have high-risk genetic syndromes (e.g., known hereditary predisposition conditions), it is advisable to consult with your doctor or a genetic counselor: studies in animal models suggest that the specific combination of genetics and microbiota can modify the response to the same diet, but the direct transfer of these results to humans requires caution and dedicated clinical studies.[1][4]

In practical and informative summary: improving carbohydrate quality, increasing fiber intake, and limiting high-glycemic index and highly processed foods is a reasonable choice supported by broad public health recommendations, even if the microbiota-butyrate mechanism remains one piece of a complex picture.[5][6]

Key points to remember

• The microbiota transforms carbohydrates into metabolites (butyrate, acetate, propionate) that influence intestinal tissue.
• In genetically predisposed murine models, butyrate can increase proliferation and polyp formation; in other contexts, it can be protective.
• Human observational studies yield inconsistent results: some meta-analyses report weak or inconsistent associations between total carbohydrate intake and colorectal risk.
• Carbohydrate quality (fiber, whole vs. refined) is a relevant factor for prevention and microbiota modulation.
• For individuals with high genetic risk, dietary decisions should be evaluated with specialists; there is no single recommendation valid for everyone.

Limitations of the evidence

Difference between observational studies and causal evidence: epidemiological studies show associations that can be influenced by dietary measurement errors, confounders (lifestyle, obesity, smoking), and geographical variability. Direct causal evidence in humans is scarce; many mechanistic explanations come from controlled animal models or cell cultures.[5][6]

Methodological limitations: in animal models, microbial composition and diet are highly controlled and not always representative of human complexity. Furthermore, the local concentration of metabolites and the presence of specific genetic mutations strongly influence the experimental result.[1][2]

Context variability: the response to a certain level of butyrate depends on the microbiota composition, the overall diet, the inflammatory state, and the host's genetic characteristics. For this reason, seemingly contradictory results (butyrate protective vs. promoter) are consistent with a strong dependence on the biological context.[2][3][4]

Need for cautious interpretation: until well-designed prospective and interventional clinical studies are available, public health recommendations must be based on overall evidence and prudence, emphasizing carbohydrate quality and established colorectal prevention strategies.

Editorial conclusion

Recent research has illuminated relevant biological pathways: the microbiota and its metabolites are active components in the relationship between diet and colorectal carcinogenesis. However, the available evidence does not justify absolute statements or indiscriminate behavioral changes for the entire population. For most people, adopting a fiber-rich diet low in refined carbohydrates remains a reasonable measure consistent with prevention recommendations. For those at increased genetic risk, the best choice is personalized medical consultation that considers family history, genetics, and individual clinical conditions.

Editorial note

Updated version of a previously published article, revised according to criteria of scientific accuracy, transparency, and institutional informative language. The information presented is for informational purposes only and does not replace personalized medical consultation.

Scientific research

The main sources cited in the text (listed with verified DOIs):

1. Belcheva A, Irrazabal T, Robertson SJ, Streutker C, Maughan H, Rubino S, et al. Gut microbial metabolism drives transformation of Msh2-deficient colon epithelial cells. Cell. 2014. https://doi.org/10.1016/j.cell.2014.04.051
2. Donohoe DR, et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell. 2012. https://doi.org/10.1016/j.molcel.2012.08.033
3. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013. https://doi.org/10.1038/nature12721
4. Donohoe DR, Holley D, Collins LB, Montgomery SA, Whitmore AC, Hillhouse A, et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov. 2014;4(12):1387-1397. https://doi.org/10.1158/2159-8290.CD-14-0501
5. Carbohydrates, glycemic index, glycemic load, and colorectal cancer risk: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2012. https://doi.org/10.1007/s10552-012-9918-9
6. Dietary carbohydrate intake, glycaemic index, glycaemic load and digestive system cancers: an updated dose–response meta-analysis. British Journal of Nutrition. 2019. https://doi.org/10.1017/S0007114519000424
7. Butyrate ameliorates colorectal cancer through regulating intestinal microecological disorders. Anti-Cancer Drugs (manuscript/abstract on experimental models). 2022. https://doi.org/10.1097/CAD.0000000000001413
8. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8+ T cells. Immunity. 2019. https://doi.org/10.1016/j.immuni.2019.06.002